Skip to content

MEDI

GradeDNew York Stock Exchange Arca

Harbor Health Care ETF (MEDI)

Active Equity · Harbor · Inception 2022-11-16

$32.55−0.72 (−2.18%)

As of Sep 23, 2026, 3:10 PM EDT

History starts Nov 17, 2022.
Intraday session: down, 66 prints from 33.27 to 32.55. Range 32.33 to 33.34. Use the arrow keys to read each point.$32.25$32.75$33.00$33.2510 AM12 PM2 PM4 PM
Expense ratio
0.80%
Fund size
$42M
1Y return
+17.0%
Yield · Last 12 months
0.23%
Holdings
45
Volume · 30D
0M sh
NAV per share
$33.25
52W range
low $27.50high $35.60

The ETF.net MEDI Grade

D

39/ 100

Rank 29 of 35 in US Active Sector

Confidence High

Six-pillar profile for MEDI. Scores out of 100: Cost 26, Risk 41, Mission 63, Tradability 53, Holdings 46, Durability 57. Strongest: Mission (63). Weakest: Cost (26). Leans toward Mission and Durability.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 39 of 100 sits in the D band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    DScore 26
    Category rank26/35 · mid-pack
  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    BScore 63
    Category rank7/9 · bottom quartile
  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    CScore 41
    Category rank25/35 · mid-pack
  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    CScore 53
    Category rank17/35 · top 49%
  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    CScore 46
    Category rank23/35 · mid-pack
  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    BScore 57
    Category rank16/35 · top 46%

Graded as of Sep 22, 2026

Our read on MEDI

ETF.net Research

DRoughly 40 health care stocks, hand-picked across any size, from big pharma to small biotech. It's a concentrated stock-picker's book benchmarked to a growth health care index, not a hold-everything sector basket.

Stated mandate

Seeks long-term growth of capital by primarily investing in common and preferred equity securities of companies of any market capitalization. Normally, at least 80% of net assets plus investment borrowings are invested in companies principally engaged in health care-related products and services.

Why people hold it

  1. 01About 40 names, not hundreds. Each pick has room to matter, which is the whole point of hiring an active manager instead of buying the entire sector.
  2. 02The mandate is explicit: at least 80% of assets in health care companies, any market cap, common or preferred shares. Big pharma and small biotech are both fair game.
  3. 03The yardstick is named up front, the Russell 3000 Growth Health Care Index, so the growth lean is disclosed rather than discovered later.

Worth knowing

  1. 01The 0.80% expense ratio sits above the median for actively managed US equity ETFs, so the stock picking carries a higher bar to clear.
  2. 02This is a small fund that doesn't trade heavily, which can mean wider bid-ask spreads than the giant sector index products.
  3. 03Payouts land once or twice a year, and a 40-stock growth portfolio reacts to single-name drug and trial news far more than a broad sector basket.

MEDI Holdings

As of Sep 20, 2026, 6:04 AM
Asset class
Stocks
Holdings
45
Top-10 weight
61%
Largest holding
LLY21.7%

Sectors

  • Health Care100.0%

Geography

  • United States77.51%
  • Denmark15.71%
  • Netherlands3.72%
  • France2.13%
  • Switzerland0.48%
  • Canada0.46%

Developed 100% · Emerging 0% of the foreign sleeve

The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001LLYELI LILLY & CO21.72%8,038$9M569
002ASCENDIS PHARMA A/S15.69%27,992$7M1
003RYTMRHYTHM PHARMACEUTICALS INC3.95%17,007$2M81
004ARGNFARGENX SE - ADR3.70%1,585$2M13
005NTRANATERA INC3.04%3,543$1M223
006GILDGILEAD SCIENCES INC2.87%8,101$1M482
007INSMINSMED INC2.81%9,656$1M183
008ABBVABBVIE INC2.63%4,250$1M511
009GHGUARDANT HEALTH INC2.56%5,964$1M171
010PCVXVAXCYTE INC2.47%17,438$1M106
011PODDINSULET CORP2.26%6,809$964K220
012CORCENCORA INC2.18%3,005$930K327
013RVMDREVOLUTION MEDICINES INC2.12%4,592$904K169
014DHRDANAHER CORP2.05%4,122$876K327
015MCKMCKESSON CORP2.05%993$873K356

Showing 1–15 of 43 holdings

MEDI Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

MEDI$11,695
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. MEDI $11,695. SPY $11,723. Use the arrow keys to read each point.$9,292$11,028$12,765Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for MEDI. Periods over one year show the average yearly return.
PeriodMEDI
Year to date+5.7%
1 month−5.0%
3 months+6.7%
1 year+17.0%
3 years+15.7%per year
5 yearsFund is under 5 years oldper year
10 yearsFund is under 10 years oldper year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for MEDI
YearReturn barMEDI
2026 YTD+5.7%
2025+27.1%
2024+0.6%
2023+24.8%
2022+2.6%

History from Nov 17, 2022

MEDI in the news

ETF.net Research hasn’t filed on MEDI yet — coverage lands here as it’s written.

MEDI Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
0.23%Last 12 months
Payout per share
$0.08Last 12 months
Last payment
$0.08 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Annual

Distribution history

2023–2026

One bar per payment. 3 payments from 2023 to 2026 YTD. Dec 21, 2023 $0.46; Dec 20, 2024 $0.13; Dec 19, 2025 $0.08. Use the arrow keys to read each point.2023202420252026YTD
Ex-datePay dateAmount per share
Dec 19, 2025Dec 24, 2025$0.08
Dec 20, 2024Dec 26, 2024$0.13
Dec 21, 2023Dec 27, 2023$0.46

MEDI Risk

How much the fund’s monthly returns vary, scaled to a year.
17.7%
Annualised · 36 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.69
vs 3-month T-bills · to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−19.3%
46 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.73
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

MEDI Cost

Expense ratio0.80%
  • The middle half of US Active Sector funds
  • Median 0.65%

24 of the 33 US Active Sector funds charge less.

MEDI costs $80.00 a year on $10,000. The median US Active Sector fund costs $65.00.